New TPK 2100 Critical Flow Controller for dry powder inhaler testing

5 Dec 2017

A highly automated system to speed up testing, improve reproducibility, and enhance data output and recording.

Copley Scientific will be presenting its new 3rd generation Critical Flow Controller – the TPK 2100 – for the testing of dry powder inhalers (DPIs) at the 2017 Drug Delivery to the Lungs conference (DDL2017) in Edinburgh. The company is showcasing this latest TPK model to highlight a series of new capabilities, all intended to make dry powder inhaler testing more automated, more reproducible and more efficient.

New TPK 2100 Critical Flow Controller for dry powder inhaler testing

The newly introduced TPK 2100 builds on Copley’s heritage of TPK models, an international standard in the field of DPI testing equipment, and is ideally suited to the needs of formulators and quality control scientists. It sets a new benchmark for the set-up, control and documentation of all the parameters associated with the measurement of delivered dose uniformity and aerodynamic particle size distribution (APSD) by cascade impaction, in accordance with the US and European Pharmacopoeias.

Anna Sipitanou, Business Development Manager at Copley Scientific, comments: “The new TPK 2100 has already generated extremely positive feedback from customers who have interacted with it, both at RDD Europe back in April and since its launch. We think it will be a big hit at DDL, as we give live demonstrations to inhaler testing analysts and laboratory managers alike. It is rewarding to know that the advancements we have incorporated into the TPK 2100 look set to benefit both existing and new customers, making a substantial difference to productivity and efficiency in the execution of these important tests.”

Designed to replace the well-established TPK 2000, significant new features are built into the TPK 2100. A new ‘fly-by-wire’ flow control valve allows operation to be automated. Inhaler pressure drop, P1, and test flow rate are accurately and rapidly set by the TPK 2100 during test set-up, whilst in-line flow measurement can be accommodated and in-situ impactor leak testing is fully automated for the first time. The user is warned if the important P3/P2 ratio is greater than 0.5, giving full confidence that tests are conducted under sonic flow conditions, whilst notification is also given if the set flow rate and impactor leak rate are outside acceptance limits. Test duration is automatically calculated based on the required test volume, and the new model offers an optional footswitch and temperature/humidity module. Data output to printer and computer are standard, with enhanced monitoring and 5 different reports covering critical in-test parameters, whilst remote control via USB allows the TPK 2100 to be integrated into larger automated systems, where required. Finally, the new instrument allows users to emulate the previous generations of TPK, promoting interchangeability and integration into existing standard operating procedures (SOPs).

A new TPK 2100-R is also being launched. This is a reversed version where the flow inlet and outlets are swapped over to allow for different arrangements of testing equipment to be set up on the laboratory bench.

Read More

Related news

Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years

Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years

18 Sep 2018

China is harmonizing to ICH standards at feverish pace and will force poor quality manufacturers out of market.

Read more 
Bio processing and manufacturing league table ranks US top and China bottom

Bio processing and manufacturing league table ranks US top and China bottom

3 Sep 2018

US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest.

Read more 
Innovation hindered by regulators

Innovation "hindered by regulators"

27 Aug 2018

CPhI Annual Report expert sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move past regulatory diktats.

Read more 
Middle East and Africa pharma economy to reach US$38.8 billion by 2021

Middle East and Africa pharma economy to reach US$38.8 billion by 2021

17 Aug 2018

CPhI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing.

Read more 
South Korea's finished drug market growth driven by generics

South Korea's finished drug market growth driven by generics

16 Jul 2018

FDF launches at CPhI Korea as country set to become regional hub.

Read more 
CPhI Worldwide opens entries for 15th Annual Pharma Awards

CPhI Worldwide opens entries for 15th Annual Pharma Awards

5 Jul 2018

Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.

Read more 
I Holland woos exhibition visitors with new tabletting technologies

I Holland woos exhibition visitors with new tabletting technologies

28 Jun 2018

Company's Wear Indicator Layer attracts the most attention.

Read more 
Ingredients to improve bioprocess manufacturing efficiency

Ingredients to improve bioprocess manufacturing efficiency

27 Jun 2018

Experts warn bio industry needs to do more to create a sustainable pipeline of talent.

Read more 
Collaboration facilitates continuous manufacturing

Collaboration facilitates continuous manufacturing

14 Jun 2018

Companies working together to help the pharmaceutical industry overcome the different challenges involved in adopting continuous manufacturing.

Read more 
Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital

Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital

12 Jun 2018

The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences.

Read more